The growing use of real-world data (RWD) in oncology is essential to complement the limitations of clinical trials, which often involve narrowly selected patient populations under specific conditions. In contrast, RWD captures how cancer care is delivered in routine practice across diverse demographics, comorbidities, and healthcare systems. This is particularly critical in oncology, where treatment… Continue reading Bridging Gaps in Oncology RWE: Key Challenges and Practical Solutions
Category: Electronic Medical Records
Challenges in Conducting RWE Research in Lifestyle-Driven Therapeutic Areas
Real-world evidence (RWE) research plays a critical role in understanding disease progression, treatment effectiveness, and patient outcomes outside of controlled clinical trial settings. However, in therapeutic areas where lifestyle and behavioral factors significantly influence disease onset and progression, such as metabolic disorders, cardiovascular diseases, and mental health conditions – RWE studies face unique challenges. A… Continue reading Challenges in Conducting RWE Research in Lifestyle-Driven Therapeutic Areas
Understanding Standard of Care and its Role in RWE Research
Standard of care (SoC) plays a critical role in healthcare and research, acting as a benchmark for what is widely accepted as appropriate medical treatment or practice in a given context. It is shaped by clinical guidelines, expert consensus, and evidence-based practices. However, its application is not static; it evolves based on emerging evidence, technological… Continue reading Understanding Standard of Care and its Role in RWE Research
The Evolving Integration of NGS Data into EMRs: Transforming Clinical Research and Precision Medicine
Next-Generation Sequencing (NGS) is a technology that allows the rapid sequencing of entire genomes, targeted regions, or specific sets of genes. It represents a significant advancement that enables the parallel sequencing of millions of DNA fragments simultaneously. NGS can be used for a variety of applications, including whole-genome sequencing (WGS), whole-exome sequencing (WES), targeted gene… Continue reading The Evolving Integration of NGS Data into EMRs: Transforming Clinical Research and Precision Medicine
RWD for EMA Regulatory Submissions: Differences in Use for Pre- vs. Post-Approval
Real‐world evidence (RWE) has an increasing role in both pre-, and post- approval applications to support the authorization of new medicines and indications, or to address post-marketing safety concerns. Therefore, the use of Real-World Data (RWD) in regulatory processes at the European Medicines Agency (EMA) varies depending on whether it is being used for… Continue reading RWD for EMA Regulatory Submissions: Differences in Use for Pre- vs. Post-Approval